Clinical trial
A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen…
NCT00240773 · Johnson & Johnson Consumer and Personal Products Worldwide, Industry · Completed
Key facts
| NCT number | NCT00240773 |
|---|---|
| Title | A Safety and Effectiveness Study of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee |
| Official title | A Randomized, Double-Blind, Long-Term Comparative Study Evaluating the Safety and Efficacy of Acetaminophen (4000 mg/Day) and Naproxen (750 mg/Day) in the Treatment of Osteoarthritis of the Hip or Knee |
| Lead sponsor | Johnson & Johnson Consumer and Personal Products Worldwide, Industry |
| Collaborators | McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Hip, Knee |
| Intervention type | Drug |
| Interventions | acetaminophen, naproxen |
| Enrollment | 581 |
| Completion | Jun 1, 2003 |
| First posted | Oct 18, 2005 |
| Last update posted | Jun 19, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: